Quality of Life Effects of Ovarian Suppression in the Suppression of Ovarian Function Trial

被引：1
|
作者：
Tomao, Federica [1 ,2 ]
Papa, Anselmo
Tomao, Silverio [3 ]
机构：
[1] European Inst Oncol, Milan, Italy
[2] Univ Rome Sapienza, Rome, Italy
[3] Univ Rome Sapienza, Latina, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 34期
关键词：
PREMENOPAUSAL BREAST-CANCER; PATIENT-REPORTED OUTCOMES; ADJUVANT EXEMESTANE; ENDOCRINE TREATMENT; WOMEN; TAMOXIFEN;
D O I：
10.1200/JCO.2016.68.8218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4188 / +
页数：2
相关论文
共 50 条
  • [21] Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?
    Roof, Kelsey A.
    Andre, Kerri E.
    Modesitt, Susan C.
    Schirmer, Austin
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 53
  • [22] Adjuvant ovarian function suppression and cognitive function in women with breast cancer
    Kelly-Anne Phillips
    Meredith M Regan
    Karin Ribi
    Prudence A Francis
    Fabio Puglisi
    Meritxell Bellet
    Simon Spazzapan
    Per Karlsson
    Daniel R Budman
    Khalil Zaman
    Ehtesham A Abdi
    Susan M Domchek
    Yang Feng
    Karen N Price
    Alan S Coates
    Richard D Gelber
    Paul Maruff
    Frances Boyle
    John F Forbes
    Tim Ahles
    Gini F Fleming
    Jürg Bernhard
    British Journal of Cancer, 2016, 114 : 956 - 964
  • [23] Adjuvant ovarian function suppression and cognitive function in women with breast cancer
    Phillips, Kelly-Anne
    Regan, Meredith M.
    Ribi, Karin
    Francis, Prudence A.
    Puglisi, Fabio
    Bellet, Meritxell
    Spazzapan, Simon
    Karlsson, Per
    Budman, Daniel R.
    Zaman, Khalil
    Abdi, Ehtesham A.
    Domchek, Susan M.
    Feng, Yang
    Price, Karen N.
    Coates, Alan S.
    Gelber, Richard D.
    Maruff, Paul
    Boyle, Frances
    Forbes, John F.
    Ahles, Tim
    Fleming, Gini F.
    Bernhard, Juerg
    BRITISH JOURNAL OF CANCER, 2016, 114 (09) : 956 - 964
  • [24] Ovarian Suppression in Premenopausal Women
    不详
    GYNAKOLOGE, 2018, 51 (09): : 689 - 689
  • [25] Ovarian suppression and breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2015, 16 (02): : E56 - E56
  • [26] Temporary Ovarian Suppression With Goserelin and Ovarian Function Protection in Patients With Breast Cancer Undergoing Chemotherapy
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3339 - 3340
  • [27] LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients
    不详
    ONCOLOGY-NEW YORK, 2018, 32 (04): : 171 - 179
  • [28] Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial
    Bliss, J. M.
    Johnson, L.
    Lawrence, D.
    Peto, J.
    Price, D.
    Yarnold, J.
    Barrett-Lee, P.
    Brunt, A. M.
    Dodwell, D.
    Earl, H.
    Fernando, I.
    Foster, L.
    George, W. D.
    Harnett, A. M.
    Perren, T.
    Poole, C.
    Raina, V.
    Robinson, A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07): : 516 - 525
  • [29] Depression, sexual dysfunction and quality of life among breast cancer patients with ovarian function suppression: A cross sectional study between ovarian ablation verse GnRH agonists
    Xu, Junnnan
    Sun, Tao
    CANCER RESEARCH, 2021, 81 (04)
  • [30] Cognitive function and quality of life in ovarian cancer
    Correa, Denise D.
    Hess, Lisa M.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 404 - 409
12345